Effects of nimodipine on salicylate ototoxicity

Annals of Otology, Rhinology and Laryngology

Volumn 111, Issue 12, 2002, Pages 1092-1096

  Ochi, Kentaro ^a,b   Kinoshita, Hirotsugu ^a   Nishino, Hirohito ^a   Kenmochi, Mutsumi ^a   Ohashi, Toru ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Toyoko Hospital   (Japan)

Author keywords

Cochlear blood flow; Compound action potential; Guinea pig; Nimodipine; Salicylate

Indexed keywords

NIMODIPINE; SALICYLIC ACID;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CALCIUM CELL LEVEL; CALCIUM CONDUCTANCE; CELL SYNCHRONIZATION; COCHLEA BLOOD FLOW; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG EFFECT; GUINEA PIG; HEARING IMPAIRMENT; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL;

EID: 0036908073     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940211101206     Document Type: Article

References (20)

1. Myers EN, Bernstein JM, Fastiropolous G. Salicylate ototoxicity. N Engl J Med 1965;273:587-90.
2. Mongan E, Kelly P, Nies K, Porter WW, Paulus HE. Tinnitus as an indication of therapeutic serum salicylate levels. JAMA 1973;226:142-5.
3. McFadden D, Plattsmier HS, Pasanen EG. Aspirin-induced hearing loss as a model of sensorineural hearing loss. Hear Res 1984;16:251-60.
4. Day RO, Graham GG, Bieri D, et al. Concentration-response relationships for salicylate-induced ototoxicity in normal volunteers. Br J Pharmacol 1989;28:695-702.
5. Puel J-L, Bobbin RP, Fallon M. Salicylate, mefenamate, meclofenamate, and quinine on cochlear potentials. Otolaryngol Head Neck Surg 1990;102:66-73.
6. Dieler R, Shehata-Dieler WE, Brownell WE. Concomitant salicylate-induced alterations of outer hair cell subsurface cisternae and electromotility. J Neurocytol 1991;20:637-53.
7. Ochi K, Eggermont JJ. Effects of salicylate on neural activity in cat primary auditory cortex. Hear Res 1996;95:63-76.
8. Møller AR. Pathophysiology of tinnitus. Ann Otol Rhinol Laryngol 1984;93:39-44.
9. Eggermont JJ. Tinnitus: Some thoughts about its origin. J Laryngol Otol Suppl 1984;9:31-7.
10. Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm - A controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983;308:619-24.
11. Gelmers HJ. Calcium-channel blockers: Effects on cerebral blood flow and potential uses for acute stroke. Am J Cardiol 1985;55:144B-148B.
12. Davies E, Knox E, Donaldson I. The usefulness of nimodipine, an L-calcium channel antagonist, in the treatment of tinnitus. Br J Audiol 1994;28:125-9.
13. Lassen LF, Hirsch BE, Kamerer DB. Use of nimodipine in the medical treatment of Meniere's disease: Clinical experience. Am J Otol 1996;17:577-80.
14. Jastreboff PJ, Brennan JF. Specific effects of nimodipine on the auditory system. Ann N Y Acad Sci 1988;522:716-8.
15. Jastreboff PJ, Brennan JF, Sasaki CT. Quinine-induced tinnitus in rats. Arch Otolaryngol Head Neck Surg 1991;117:1162-6.
16. Boettcher FA, Caldwell RK, Gratton MA, White DR, Miles LR. Effects of nimodipine on noise-induced hearing loss. Hear Res 1998;121:139-46.
17. Kay IS, Davies WE. The effect of nimodipine on salicylate ototoxicity in the rat as revealed by the auditory evoked brain-stem response. Eur Arch Otorhinolaryngol 1993;250:51-4.
18. 2+ antagonist, reverses the negative summating potential recorded from the guinea pig cochlea. Hear Res 1990;46:277-87.
19. 2+dependent and nifedipine-sensitivity of vascular tone and contractility in the isolated superfused spiral modiolar artery in vitro. Hear Res 1998;118:90-100.
20. Coleman JK, Dengerink HA, Wright JW. Effects of hydroxyethyl starch, nimodipine, and propylene glycol on cochlear blood flow. Otolaryngol Head Neck Surg 1991;105:840-4.